It is important to remember that all drugs may cause certain reactions. Boniva can also cause side effects in some patients. Boniva, or ibandronate sodium, is manufactured by Roche Therapeutics Inc and Genentech. It is approved by the FDA as a once-monthly oral treatment of postmenopausal osteoporosis symptoms in women. The one tablet per month treatment must be prescribed by your doctor.